Journal of Diagnostics Concepts & Practice››2018,Vol. 17››Issue (02): 141-146.doi:10.16150/j.1671-2870.2018.02.004
• Experts forum •Previous ArticlesNext Articles
Received:2018-03-21Online:2018-04-25Published:2018-04-25| [1] Tkach M, Théry C. Communication by extracellular vesicles: Where we are and where we need to go[J]. Cell,2016,164(6):1226-1232. [2] Zaborowski MP, Balaj L, Breakefield XO, et al. Extracellular Vesicles: Composition, Biological Relevance, and Methods of Study[J]. Bioscience,2015,65(8):783-797. [3] Raposo G, Nijman HW, Stoorvogel W,et al.B lymphocytes secrete antigen-presenting vesicles[J]. J Exp Med,1996, 183(3):1161-1172. [4] Zitvogel L, Regnault A, Lozier A, et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes[J]. Nat Med,1998, 4(5):594-600. [5] Théry C, Amigorena S, Raposo G, et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids[J]. Curr Protoc Cell Biol,2006. [6] Stahl PD, Barbieri MA. Multivesicular bodies and multivesicular endosomes: the "ins and outs" of endosomal traffic[J]. Sci STKE,2002,2002(141):pe32. [7] Clayton A, Turkes A, Dewitt S, et al. Adhesion and signaling by B cell-derived exosomes: the role of integrins[J]. FASEB J,2004,18(9):977-999. [8] Gould SJ, Booth AM, Hildreth JE. The Trojan exosome hypothesis[J]. Proc Natl Acad Sci U S A,2003,100(19):10592-10597. [9] Clayton A, Harris CL, Court J, et al. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59[J]. Eur J Immunol,2003,33(2):522-531. [10] Wolfers J, Lozier A, Raposo G, et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming[J]. Nat Med,2001,7(3):297-303. [11] Chen TS, Lai RC, Lee MM, et al. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs[J]. Nucleic Acids Res,2010,38(1):215-224. [12] Beninson LA, Fleshner M. Exosomes: an emerging factor in stress-induced immunomodulation[J]. Semin Immunol,2014,26(5):394-401. [13] Carlsson L, Nilsson O, Larsson A, et al. Characteristics of human prostasomes isolated from three different sources[J]. Prostate,2003,54(4):322-330. [14] Chaput N, Flament C, Viaud S, et al. Dendritic cell derived-exosomes: biology and clinical implementations[J]. J Leukoc Biol,2006,80(3):471-478. [15] Théry C, Duban L, Segura E, et al. Indirect activation of na?ve CD4+ T cells by dendritic cell-derived exosomes[J]. Nat Immunol,2002,3(12): 1156-1162. [16] Munich S, Sobo-Vujanovic A, Buchser WJ, et al. Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands[J]. Oncoimmunology,2012,1(7):1074-1083. [17] Romagnoli GG, Zelante BB, Toniolo PA, et al. Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets[J]. Front Immunol,2014,5:692. [18] Klibi J, Niki T, Riedel A, et al. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells[J]. Blood, 2009,113(9):1957-1966. [19] Liu ZM, Wang YB, Yuan XH. Exosomes from murine-derived GL26 cells promote glioblastoma tumor growth by reducing number and function of CD8+ T cells[J]. Asian Pac J Cancer Prev, 2013,14(1):309-314. [20] Tominaga N, Kosaka N, Ono M, et al. Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier[J]. Nat Commun,2015,6:6716. [21] Felicetti F, De Feo A, Coscia C, et al. Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma[J]. J Transl Med,2016,14(1):56. [22] Altieri SL, Khan AN, Tomasi TB. Exosomes from plasmacytoma cells as a tumor vaccine[J]. J Immunother,2004,27(4): 282-288. [23] Cho JA, Yeo DJ, Son HY, et al. Exosomes: a new delive-ry system for tumor antigens in cancer immunotherapy[J]. Int J Cancer, 2005,114(4):613-622. [24] Hao S, Bai O, Yuan J, et al. Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes[J]. Cell Mol Immunol, 2006,3(3):205-211. [25] Au Yeung CL, Co NN, Tsuruga T, et al. Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1[J]. Nat Commun,2016,7:11150. [26] Cvjetkovic A, L?tvall J, L?sser C. The influence of rotor type and centrifugation time on the yield and purity of extracellular vesicles[J]. J Extracell Vesicles,2014,3. [27] Rani S, O'Brien K, Kelleher FC, et al. Isolation of exosomes for subsequent mRNA, MicroRNA, and protein profiling[J]. Methods Mol Biol,2011,784:181-195. [28] Vickers KC, Palmisano BT, Shoucri BM, et al. Micro RNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins[J]. Nat Cell Biol,2011, 13(4):423-433. [29] Rider MA, Hurwitz SN, Meckes DG Jr. ExtraPEG: A polyethylene glycol-based method for enrichment of extracellular vesicles[J]. Sci Rep,2016,6:23978. [30] Maas SL, de Vrij J, van der Vlist EJ, et al. Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics[J]. J Control Release,2015,200:87-96. [31] Dragovic RA, Gardiner C, Brooks AS, et al. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis[J]. Nanomedicine,2011,7(6):780-788. [32] Wyss R, Grasso L, Wolf C, et al. Molecular and dimensional profiling of highly purified extracellular vesicles by fluorescence fluctuation spectroscopy[J]. Anal Chem,2014,86(15):7229-7233. [33] Gy?rgy B, Módos K, Pállinger E, et al. Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters[J]. Blood,2011,117(4):39-48. [34] Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends[J]. J Cell Biol,2013, 200(4):373-383. [35] Lai CP, Mardini O, Ericsson M, et al. Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter[J]. ACS Nano,2014,8(1):483-494. [36] Sheridan C. Exosome cancer diagnostic reaches market[J]. Nat Biotechnol,2016,34(4):359-360. [37] Royo F, Zu?iga-Garcia P, Torrano V, et al. Transcripto-mic profiling of urine extracellular vesicles reveals alte-rations of CDH3 in prostate cancer[J]. Oncotarget,2016,7(6):6835-6846. [38] Zhang P, He M, Zeng Y, et al. Ultrasensitive microfluidic analysis of circulating exosomes using a nanostructured graphene oxide/polydopamine coating[J]. Lab Chip,2016, 16(16):3033-3042. [39] Hsu DH, Paz P, Villaflor G, et al. Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides[J]. J Immunother,2003,26(5):440-450. [40] Morse MA, Garst J, Osada T, et al. A phase Ⅰ study of dexosome immunotherapy in patients with advanced non-small cell lung cancer[J]. J Transl Med,2005,3(1):9. [41] Escudier B, Dorval T, Chaput N, et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase Ⅰ clinical trial[J]. J Transl Med,2005,3(1):10. [42] Hood JL, San RS, Wickline SA. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis[J]. Cancer Res,2011,71(11):3792-3801. [43] Ostrowski M, Carmo NB, Krumeich S, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway[J]. Nat Cell Biol,2010,12(1):19-30. [44] Thompson CA, Purushothaman A, Ramani VC, et al. Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes[J]. J Biol Chem,2013,288(14):10093-10099. [45] Chalmin F, Ladoire S, Mignot G, et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells[J]. J Clin Invest, 2010,120(2):457-471. [46] Miyanishi M, Tada K, Koike M, et al. Identification of Tim4 as a phosphatidylserine receptor[J]. Nature, 2007, 450(7168):435-439. [47] Parolini I, Federici C, Raggi C, et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells[J]. J Biol Chem,2009,284(49):34211-34222. [48] Ciravolo V, Huber V, Ghedini GC, et al. Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy[J]. J Cell Physiol,2012,227(2):658-667. [49] Kosaka N, Yoshioka Y, Tominaga N, et al. Dark side of the exosome: the role of the exosome in cancer metastasis and targeting the exosome as a strategy for cancer therapy[J]. Future Oncol,2014,10(4):671-681. |
| [1] | ZHOU Lu, LEI Hang, HONG Ye, JIN Shuang, DONG Yongqin, WANG Xuefeng, CAI Xiaohong.AwB subtype caused by a novelABO *Aallele and its molecular mechanisms[J]. Journal of Diagnostics Concepts & Practice, 2021, 20(06): 547-551. |
| [2] | LEI Hang, FAN Liangfeng, CAI Xiaohong, WANG Yuqing, LIU Xi, JIN Sha, SHEN Wei, LU Qiong, XIANG Dong, WANG Xuefeng, ZOU Wei.The study on molecular basis of ABO blood subgroups in the Chinese population[J]. Journal of Diagnostics Concepts & Practice, 2020, 19(04): 364-369. |
| [3] | GONG Ruhan, LI Jia, HUANG Kaifeng.Establishment of fluorescence PCR method using blood specimens for a rapid genetyping and its application inADRB1genotyping[J]. Journal of Diagnostics Concepts & Practice, 2020, 19(04): 402-406. |
| [4] | ZHOU Xiaona, FANG Honggang, CAO Yanfei, LI Xinna, ZHANG Lina, LU Yide.Analysis of interference factors in measurement of serum uric acid by uricase-peroxidase coupled reaction[J]. Journal of Diagnostics Concepts & Practice, 2020, 19(04): 426-429. |
| [5] | CHEN Chen, ZHANG Yue, HU Xiaobo.The clinical evaluation and optimization of alarm Threshold setting for Sysmex UF5000 UTI[J]. Journal of Diagnostics Concepts & Practice, 2020, 19(02): 168-171. |
| [6] | LI Hui, FENG Jie, HAN Lizhong.Analysis of intestinal microbial composition in specific pathogen free mice using high-throughput sequencing[J]. Journal of Diagnostics Concepts & Practice, 2020, 19(1): 55-62. |
| [7] | ZHU Chao, GUAN Jialiang, LI Zhe, LIU Yu, WANG Xuefeng, WU Wenman.Research on correlation between results of dilutedRussellviper venom time (dRVVT) test and mixing test in detection of lupus anticoagulant[J]. Journal of Diagnostics Concepts & Practice, 2020, 19(1): 28-31. |
| [8] | JIN Yanping, JIANG Ming, JIA Fangming.Application of microcolumn gel technique in safe blood transfusion[J]. Journal of Diagnostics Concepts & Practice, 2019, 18(06): 672-675. |
| [9] | LI Lei, WU Xi, XU Guanqun, LIANG Qian, DAI Jing, WU Wenman, DING Qiulan, WANG Hongli, WANG Xuefeng.Establishment and application of thrombophilia gene detection panel based on next generation sequencing in identification of genetic background of Chinese patients with venous thromboembolism[J]. Journal of Diagnostics Concepts & Practice, 2019, 18(04): 394-401. |
| [10] | .[J]. Journal of Diagnostics Concepts & Practice, 2019, 18(2): 127-132. |
| [11] | .[J]. Journal of Diagnostics Concepts & Practice, 2019, 18(1): 107-108. |
| [12] | ZHANG Haiou, CHENG Weiwei, HU Wenjing, LIU Mengdi, FAN Jianxia, QIAN Yiyuan.Exploration of an automated prenatal Down syndrome screening adjustment protocol based on patient samples[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(05): 547-551. |
| [13] | WANG Dengfeng, CUI Wenyan, ZOU Wei, LI Fang, WANG Xuefeng, CAI Xiaohong.Molecular mechanism of Axsubtype caused by p.M142I mutation in alpha 1-3-N-acetylgalactosaminyltransferase[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(03): 260-265. |
| [14] | SHEN Xiaohong, CHEN Huifen, ZHANG Jun, YE Jianbo, ZHANG Xianhua.Distribution of pathogenic bacteria in neonatal bloodstream infection and analysis of drug resistance during 2014 to 2017[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(03): 266-271. |
| [15] | KONG Cunquan, HE Yi, LIAN Lixia, XU Shen, WANG Xuefeng, ZOU Wei, CAI Xiaohong.AxB blood group phenotype caused by ABO gene c.2T>C mutation and GTA aberrant translation[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(02): 155-158. |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
